Archive for 2019

GLP-1 Receptor Agonists: Where do these non-insulin injectables, and newly approved oral option, fit in for the treatment of Type 2 Diabetes Mellitus?

GLP-1 Receptor Agonists:

Where do these non-insulin injectables, and newly approved oral option, fit in for the treatment of Type 2 Diabetes Mellitus?

By: Cedrice Davis, MD

Advances in treatment options for Diabetes have expanded over the last decade. While first-line therapy for the treatment of Diabetes has remained Metformin and comprehensive lifestyle modifications, several professional organizations, including the American Diabetes Association1, American College of Cardiology2, American Heart Association3, and American College of Clinical Endocrinologists4, have updated their guidelines to reflect a wider playing field for 2nd line options. Glucagon Like Peptide – 1 Receptor Agonists (GCP-1 RA) is one of those options.

Despite guideline updates, utilization of GLP-1 RA in the primary care setting remains relatively low.5 As an outpatient family physician with an office that participates in diabetes clinical research trials, I think it is important that we take a look at why this class of medicines should be part of the primary care physician’s armamentarium in the fight to control this disease.

GLP-1 is a member of the incretin family of glucoregulatory hormones.  It is secreted in response to food ingestion. GLP-1 RA therapies attempt to correct the dysregulation/dysfunction of normal physiology that contributes to the diabetes disease state.  GLP-1 RAs impact several core defects present in type 2 diabetes.6Background:

How do GLP-1 RA work?6

  1. Glucose-dependent increase in insulin secretion from pancreas. It does so by stimulating the beta cells of the pancreas in the setting of a glucose load.
  2. Glucose-dependent decrease of glucagon secretion from the liver. In Diabetes, the hormone glucagon is oversecreted causing an unwanted release of glucose from the liver. The suppression of the glucagon results in a welcomed decrease of glucose from the liver.
  3. Increased satiety resulting in a suppressed appetite. This occurs via receptors in the central nervous system.
  4. Delayed gastric emptying. This results in lower postprandial glucose levels.
  5. Protection of ?-cell mass (demonstrated in animal models).

GLP-1 RA Products Available:

There is currently one newly approved oral GLP-1 RA and six injectable GLP-1 RAs available in the U.S. Dulaglutide (Trulicity), exenatide (Bydureon), exenatide (Byetta), liraglutide (Victoza), lixisenatide (Adlyxin), and semaglutide injectable (Ozempic) and now semaglutide oral (Rybelsus). (Click on brand name for link to product information)

Expected Clinical Outcomes:6,7,8

A1C reduction: 0.8-1.8%

Body weight reduction: 2-14 lbs

Efficacy and safety between GLP-1RAs vary. All have demonstrated cardiovascular safety, but liraglutide has an FDA approved indication to prevent CVD in high risk patients. Other GLP1 RAs are currently under FDA review for a CVD prevention indication (e.g., dulaglutide, semaglutide).

Cost:

Out of pocket expense for the patient will vary depending on insurance coverage.  Most manufacturers offer copay assistance for commercially insured patients and financial assistance for low income patients.

Tolerability: 6,7,9

GLP-1 RAs are generally well tolerated, with nausea and vomiting being the most common adverse event.  It is important to inform patients initiating GLP-1 RA therapy that this may occur initially, but it is usually transient and is typically mild to moderate in nature. If nausea is bothersome, the patient may be advised to eat smaller meals and avoid spicy or high-fat meals.  For patients already on the GLP-1 RA that experience nausea and vomiting with dose titration, consider decreasing back to the last tolerated dose for 1 week before repeating the incremental dosing steps.  The ADA standards of care note that renal dosing adjustments are required for exenatide and lixisenatide.1   Injection site reactions have also been reported.

What about GLP-1 RA and risk of pancreatitis? 9,10

Type 2 diabetes is a risk factor for development of acute pancreatitis, and studies of patients treated with GLP-1 RAs have reported that pancreatitis may occur more frequently with these medications, but results have been mixed. According to the PIs of all GLP-1 RAs, if pancreatitis is suspected, these drugs should be discontinued, and if acute pancreatitis is confirmed, they should not be restarted. The FDA and the European Medicines Agency (EMA) have agreed that assertions concerning a causal association between incretin-based drugs and pancreatitis or pancreatic cancer, as expressed in some scientific literature and in the media, are inconsistent with current data; however, the FDA and the EMA have not reached a final conclusion regarding such a causal relationship.

What about GLP-1 RA and risk of thyroid tumors? 6,7

In rodent models, GLP-1RAs have been linked to the release of calcitonin, and the potential formation of thyroid tumors, but there is no evidence of a causal relationship between GLP-1 RAs and thyroid tumors in humans. Personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome is contraindicated according to the FDA PI for the long acting GLP-1 RAs dulaglutide, liraglutide, semaglutide and exenatide once weekly.

COMING SOON: 11

Different delivery systems for GLP-1 RAs are being investigated. Oral Semaglutide (Rybelsus) was approved by the FDA on September 20, 2019 and is now available in pharmacies. Other oral options are also being investigated as well as an implantable osmotic pump…. stay tuned!

References:

  1. American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes—2019. Diabetes Care 2019;42(Suppl. 1): S1-S193. https://doi.org/10.2337/dc19-S009
  2. Das SR, et al. 2018 ACC expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a report of the American College of Cardiology Task Force on expert consensus decision pathways [published online November 26, 2018]. J Am Coll Cardiol. https://doi.org/10.1016/j.jacc.2018.09.020
  3. Arnett DK, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol 2019 Mar 17; [e-pub]. https://doi.org/10.1016/j.jacc.2019.03.010
  4. Alan J. Garber, et al. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2019 Executive Summary. Endocrine Practice: January 2019, Vol. 25, No. 1, pp. 69-100. https://doi.org/10.4158/EP151126.CS
  5. Raval, A. D., et al. National Trends in Diabetes Medication Use in the United States: 2008 to 2015. Journal of Pharmacy Practice.2018. https://doi.org/10.1177/0897190018815048
  6. Drucker DJ. Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1. Cell Metab.2018 Apr 3;27(4):740-756. https://doi.org/10.1016/j.cmet.2018.03.001
  7. Hinnen, D., et al. Glucagon-like peptide 1 receptor agonists for type 2 diabetes. Diabetes Spectr, 30 (3) 2017;202-210. https://doi.org/10.2337/ds16-0026
  8. Pratley RE, et al. Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial. Lancet Diabetes Endocrinol 2018;6:275–86. https://doi.org/10.1016/S2213-8587(18)30024-X
  9. Thomsen RW, et al. Incretin-based therapy and risk of acute pancreatitis: a nationwide population-based case-control study. Diabetes Care 2015;38:1089–1098. https://doi.org/10.2337/dc13-2983
  10. Egan AG, et al. Pancreatic safety of incretin-based drugs—FDA and EMA assessment.New England Journal of Medicine. 2014;370(9):794-797. https://doi.org/1056/NEJMp1314078
  11. Meier, J.J., et al. Incretin-based therapies: where will we be 50 years from now? Diabetologia. 2015;58: 1745. https://doi.org/10.1007/s00125-015-3608-6

Georgia Healthy Family Alliance Announces Northeast Georgia Health System as Presenting Sponsor of Tar Wars Vaping Prevention Program for Gainesville Area Elementary Schools

 Gainesville, Ga. – The Georgia Healthy Family Alliance (GHFA), the philanthropic arm of the Georgia Academy of Family Physicians, today announced Northeast Georgia Health System (NGHS) as presenting sponsor of Tar Wars, a program developed by the American Academy of Family Physicians (AAFP) focused on educating students as early as 4th grade about the dangers of tobacco use and vaping.

In response to the epidemic of youth vaping and e-cigarette use, Georgia family physicians are partnering with the health system to present the Tar Wars program in Hall County Schools, Gainesville City Schools and surrounding counties.

From a community prevention effort, NGHS was eager to partner with GHFA.  “This initiative aligns with our community health improvement plan in terms of preventing lung disease and is an educational effort targeted directly at the kids in our community.  We felt very strongly about supporting this program,” says Christy Moore, Community Health Improvement Manager at NGHS.

According to the Georgia Student Health Survey administered by the Georgia Department of Education, the incidence of students who report having used a vape has increased over 100 percent in just the past two years in Hall County Schools.

“The trend is alarming and clearly dangerous for our community,” says Dr. Monica Newton, a family medicine physician at Northeast Georgia Physician’s Group and leader of the Northeast Georgia Strike Force effort.  “Not only are we seeing more illness as a direct result of vaping, we don’t always know what is contained in the vape, which is scary. I am grateful to NGHS for taking the lead to educate our children about how dangerous vaping is.”

GHFA has set a goal of raising $250,000 so that students can have access to the program for multiple years starting in the 2020 school year.

The Alliance is the philanthropic arm of the Georgia Academy of Family Physicians (GAFP).  Established in 1947, the GAFP is a member chapter of the American Academy of Family Physicians. GAFP strives to promote the health of the citizens of Georgia by advancing the specialty of Family Medicine through education, advocacy and service to family physicians in the State of Georgia. Boasting a membership of 3,200 family physicians, family medicine residents, and medical students, the organization supports those who aspire to achieve excellence and who are committed to delivering it. For more information about Tar Wars, visit www.georgiahealthyfamilyalliance.org or call us at 404-321-7445.

 

Members in the News

Altelisha Taylor, MD, MPH appointed to the AAFP Commission on Continuing Professional Development (COCPD)

The American Academy of Family Physicians Board of Directors has appointed Altelisha Taylor, MD, MPH, to the AAFP Commission on Continuing Professional Development (COCPD) for 2019-2020. Dr. Taylor’s term begins December 15, 2019.

Dr. Taylor is a PGY-1 resident at Emory University Family Medicine Residency Program in Atlanta, GA.

Congratulations Dr. Taylor!

Georgia Academy of Family Physicians Awards Dolapo Babalola, MD, FAAFP, its 2019 Family Medicine Educator of the Year Award

The Georgia Academy of Family Physicians (GAFP) awarded Dolapo Babalola, MD, FAAFP its 2019 Family Medicine Educator of the Year, for her exceptional influence on medical students and residents as faculty at Morehouse School of Medicine.

Dr. Babalola is an Associate Professor of Family Medicine and the Director of Medical Education and Rural Health at Morehouse School of Medicine in Atlanta.

Dr. Babalola has led many innovative efforts, including the Family Medicine Sub-Internship Selective Curriculum both structurally and educationally for the fourth-year medical students to promote primary care. She volunteers in the free student run clinic where she supervises and teaches students as they provide medical care for underserved and uninsured populations. She continues to develop new curricula and initiatives for medical students which includes; mid-clerkship evaluation meetings, group clinical skill sessions and National Board of Medical Examiners Subject examination prep review.

Dr. Babalola received her Doctor of Medicine from the University of Guyana School of Medicine, in Guyana. She completed Postgraduate Training at Morehouse School of Medicine and a fellowship in the Department of Family Medicine Faculty Development and Family Medicine Residency. Dr. Babalola has received the following awards; Grady Community Teacher’s Award, Outstanding Family Medicine Educator by the Morehouse Student Government Association. She was the 2nd place recipient for the Morehouse Faculty Teaching Competition and she was the 2018 GAFP Research Poster Award winner in the Practicing physician category at Georgia Academy of Family Physicians Annual Meeting.

Dr. Babalola embodies the true definition of an effective educator in Family Medicine. She is an emerging leader and we look forward to supporting her in her pursuit of being a lifelong educator.

Dr. Babalola will be among a group of four individuals honored by GAFP at the Annual Fall CME meeting in November.

 

In Memory of Our Colleagues

As this year draws to a close, the GAFP Board of Directors would like to acknowledge our members who passed away in 2019. These members were long-time, valued members of our organization, and embodied the attributes we outline in our mission – enhance the well-being of Georgians by promoting healthy practices consistent with the principles of family medicine.

Each of these members was an integral part of the communities in which they lived, and the patients they served throughout their careers.  The GAFP mourns their loss and will continue to serve as true advocates of family medicine in their memory.

Laurence T. Crimmins, MD ~ Albany

Chester R. Lapeza, MD ~ Cordele

Robert Mainor, MD ~ Smyrna

Bonnie P. Malvea, MD ~ Jonesboro

Beena S. Patel, MD ~ Sandy Springs

Allen L. Pelletier, MD ~ Augusta

Roslyn Donny Taylor, MD ~ Summerville, SC

Bradley L. Ward, MD ~ Taylorsville

 

“In the end, it’s not the years in your life that count. It’s the life in your years.

–Abraham Lincoln

Georgia Academy of Family Physicians Awards Folashade Omole, MD, FAAFP its 2019 Community & Volunteer Services Awards

 

The Georgia Academy of Family Physicians (GAFP) selected Folashade Omole, MD, FAAFP as its 2019 Community & Volunteer Services Award recipient, for her outstanding commitment to the community and efforts in raising awareness about access to and affordability of medical care in underserved communities in Atlanta.

Dr. Omole holds the Sarah & William Hambrecht Endowed Chair of Family Medicine at Morehouse School of Medicine. She is the Professor of Family Medicine and the Medical Director of MSM H.E.A.L. (Health Equity for All Lives), a student-run clinic.

Dr. Omole exemplifies what it truly means to be a volunteer not only giving of her time, but her talents as well. At MSM, she’s a role model for students and residents and goes above and beyond to commit herself to the H.E.A.L. Clinic and the Good Samaritan Health Center in Atlanta. She leads other community initiatives at Morehouse School of Medicine including community health fairs and community engagement days to screen for chronic diseases and provide education.

Dr. Omole is a graduate of the Morehouse School of Medicine Family Medicine Residency Program. She received a BSc in Physics from the University of Lagos, Nigeria; and her medical degree from Obafemi Awolowo University, lle-lfe, Nigeria; two of the foremost prestigious universities in Nigeria. In 2000, Dr. Omole was appointed Clerkship Director in the Department of Family Medicine at MSM; and Residency Program Director in September 2004. She practices the full scope of family medicine including obstetrics; and is also a licensed medical acupuncturist.

Dr. Omole has served in various roles with the Georgia Academy of Family Physicians (GAFP) including Treasurer, District 11 Director for the GAFP Board and the GAFP Executive Committee. She was the recipient of the Georgia Academy Family Physician Educator of the Year Award in 2006 and the GAFP Family Physician of the Year in 2015. Dr. Omole will be among a group of four individuals honored by GAFP.

Dr. Omole will be among a group of four individuals honored by GAFP at the Annual Fall CME meeting in November.

Listen to Archived Webinars on the GAFP Website

Did you miss a GAFP webinar? They are available to watch on the GAFP website at www.gafp.org/education/webinars/. Below is a list of past webinar topics. Please click on the title link to register to view the recorded session.

GAFP Education Webinars

The following webinars with objectives can be found on the GAFP education page:

For more information about the webinars, please contact Director of Education Felica Kenan at fkenan@gafp.org or call 404-321-7445.

 

Natural Disaster Relief Available for GAFP Members

We are aware that several Georgia communities experienced flooding and power outages on September 4-5, 2019 when Hurricane Dorian passed through Coastal Georgia. Our thoughts and prayers are with those who have been impacted by this storm.

Because damage is still being assessed in the impacted communities, we want you to know that the Georgia Academy’s Foundation (Georgia Healthy Family Alliance) has a Disaster Relief Fund to help our members who may have experienced damage to their practice.  We established this fund in 2007 and were able to help two family physicians who lost their practices when a tornado ripped through downtown Americus.

If you are aware of a family physician in need or if you have damage to your office don’t hesitate to contact us at (404) 321-7445.  Either Kara Sinkule (ksinkule@gafp.org) or Fay Fulton (ffulton@gafp.org) can assist you with filling out a simple disaster relief application.

 

Sincerely,

Patrick “PJ” Lynn, MD, FAAFP

President

Georgia Healthy Family Alliance

Foundation of the Georgia Academy of Family Physicians

www.georgiahealthyfamilyalliance.org

 

Georgia Academy Adds its Voice to AAFP Concerning the 2020 Revisions to Medicare’s Physician Fee Schedule

President Donald L. Fordham, MD submitted a letter of comment on behalf of the Georgia Academy on the proposed revisions to the 2020 physician fee schedule for Medicare.  These comments echoed many of the points that the AAFP submitted to the Centers for Medicare & Medicaid Services (CMS).  Below are some of the highlights of those comments:

The Georgia Academy respectfully offers comments on the following high-level issues for your consideration.

Office/Outpatient Evaluation and Management (E/M) Coding. The Georgia Academy supports the adoption of the work relative value units (RVUs) recommended by the RVU Update Committee (RUC) for all the office/outpatient E/M codes, the new prolonged services add-on code, and CMS’ proposal to maintain separate values for levels two through four visits rather than implement its plan for a blended payment rate for those services. However, since most family medicine practices already operate on extremely thin margins and these services have been undervalued for decades, we implore CMS to implement these changes in 2020 rather than 2021 as proposed.

Global Surgical Packages. Based upon analysis available from RAND and the Medicare Payment Advisory Commission, we believe the proposed recommendations put forth by CMS are the appropriate policy. Therefore, we strongly support CMS’ proposal to not adjust the office/outpatient E/M visits for codes with a global period to reflect the changes made to the values for office/outpatient E/M visits.

Chronic Care Management. The Georgia Academy is concerned the addition of new principal care management (PCM) codes would move away from the continuous, comprehensive, and coordinated value-based care and primary care CMS has otherwise been encouraging as a cost-effective way to care for Medicare patients. We offer alternative recommendations in the body of the letter to strengthen care for beneficiaries with chronic conditions and urge CMS to use the existing Current Procedural Terminology (CPT) coding process to make changes to these codes.

II.J. Review and Verification of Medical Record Documentation

Summary

Building on medical record documentation relief it implemented in 2019, CMS proposes to establish a general principle to allow the physician, the physician assistant (PA), or the advanced practice registered nurse (APRN) who furnishes and bills for their professional services to review and verify, rather than re-document, information included in the medical record by physicians, residents, nurses, students, or other members of the medical team. This principle would apply across the spectrum of all Medicare-covered services paid under the physician fee schedule. Because this proposal is intended to apply broadly, CMS proposes to amend regulations for teaching physicians, physicians, PAs, and APRNs to add this new flexibility for medical record documentation requirements for professional services furnished by teaching physicians, physicians, PAs, and APRNs in all settings.

Specifically, CMS proposes to amend relevant sections of its regulations to add a new paragraph entitled, “Medical record documentation.” This paragraph would specify that, when furnishing their professional services, the clinician may review and verify (sign/date) notes in a patient’s medical record made by other physicians, residents, nurses, students, or other members of the medical team, including notes documenting the practitioner’s presence and participation in the services, rather than fully re-documenting the information. CMS notes that, while the proposed change addresses who may document services in the medical record, subject to review and verification by the furnishing and billing clinician, it does not modify the scope of, or standards for, the documentation that is needed in the medical record to demonstrate medical necessity of services, or otherwise for purposes of appropriate medical recordkeeping.

CMS also proposes to make conforming amendments to its regulations to also allow physicians, residents, nurses, students, or other members of the medical team to enter information in the medical record that can then be reviewed and verified by a teaching physician without the need for re-documentation.

Georgia Academy of Family Physicians Response

The Georgia Academy strongly supports CMS’ proposals in this regard as it is long overdue. The proposed principle and related regulatory changes are consistent with prior CMS efforts to reduce the administrative burden associated with medical record documentation. They are also consistent with the team-based model of care used in family medicine practices and residencies. However, we urge CMS to clarify that multiple students and residents can enter patient information into the medical record even on the same day and during the same office visit. We encourage CMS to finalize this proposal as clarified per our recommendation in the final rule this fall.

  1. P. Payment for Evaluation and Management (E/M) Visits

Summary – Office/Outpatient E/M Visit Coding and Documentation

For calendar year 2021, for office/outpatient E/M visits (CPT codes 99201-99215), CMS proposes to adopt the new coding, prefatory language, and interpretive guidance framework adopted by the CPT Editorial Panel for CPT 2021. This includes deletion of code 99201 and acceptance of a new, single add-on CPT code for prolonged office/outpatient E/M visits (code 99XXX) that would only be reported when time is used for code-level selection and the time for a level five office/outpatient visit (the floor of the level five time range) is exceeded by 15 minutes or more on the date of service. This new add-on code would obviate the need for code GPRO1 (extended office/outpatient E/M time), which CMS had planned to implement in 2021, but now proposes to delete instead.

The one variance from CPT in this regard is that, for Medicare, CPT codes 99358 and 99359 (Prolonged E/M without direct patient contact) would no longer be reportable in association or “conjunction” with office/outpatient E/M visits. New CPT prefatory language specifies 99358 and 99359 may be reported for prolonged services on a date other than the date of a face-to-face encounter. CMS believes its proposed policy regarding 99358 and 99359 would be consistent with the way the office/outpatient E/M visit codes were resurveyed, where the RUC instructed those surveyed to consider all time spent three days prior to, or seven days after, the office/outpatient E/M visit. CMS finds the CPT language and reporting instructions related to 99358 and 99359 to be unclear and circular and believes CPT codes 99358 and 99359 may need to be redefined, resurveyed, and revalued. In the meantime, CMS seeks public input on its proposal and whether it would be appropriate to interpret the CPT reporting instructions for CPT codes 99358 and 99359 as proposed, as well as how this interpretation may impact valuation.

Georgia Academy of Family Physicians Response – Office/Outpatient E/M Visit Coding and Documentation

The Georgia Academy appreciates and strongly supports CMS’ proposal to adopt the new coding, prefatory language, and interpretive guidance framework adopted by the CPT Editorial Panel for CPT 2021. This includes deletion of code 99201 and acceptance of a new, single add-on CPT code for prolonged office/outpatient E/M visits (code 99XXX) in lieu of the code (GPRO1) CMS previously planned to use.

Changes of this magnitude may have an impact on EHRs, since most are built around the current CPT structure and 1995/1997 E/M documentation guidelines. If CMS finalizes this proposal, it must provide this updated framework to EHR vendors as soon as possible and work with the American Medical Association (AMA) and specialty societies on the physician communications and educational efforts that will be needed between now and 2021.

Regarding codes 99358 and 99359 (Prolonged E/M without direct patient contact), we acknowledge the points of confusion in the CPT guidance for use of these codes in conjunction with office/outpatient visit codes vis-à-vis the parameters in which the latter codes were surveyed for the RUC. However, we would encourage CMS to work with the CPT Editorial Panel to resolve these points of confusion between now and 2021 rather than unilaterally making 99358 and 99359 no longer reportable in conjunction with office/outpatient E/M visits for Medicare.

Part of the administrative complexity and burden that hampers our members’ ability to care for their patients is variability in payment policy among payers and payment policy at odds with guidance otherwise included in CPT. CMS’ proposal to unilaterally change its payment policy in this regard, and in conflict with CPT would add to our members’ administrative complexity and burden. Therefore, we oppose CMS’ proposal and instead urge CMS to work through the CPT process so any changes apply to more than just Medicare. As noted in the AAFP’s policy on “Coding and Payment,” the AAFP supports CPT and the coding principles it contains. Thus, the Georgia Academy believes it is important for both physicians and health plans to abide by the principles of CPT.

Summary – Office/Outpatient E/M Visit Revaluation (CPT codes 99201 through 99215)

CMS proposes to adopt the RUC-recommended work RVUs for all the office/outpatient E/M codes and the new prolonged services add-on code, effective for dates of service on or after January 1, 2021. CMS proposes to maintain separate values for levels two through four visits rather than implement its plan for a blended rate for those services.

Regarding the RUC recommendations for PE inputs for these codes, CMS proposes to remove equipment item ED021 (computer, desktop with monitor), as CMS does not believe that this item would be allocated to the use of an individual patient for an individual service. Instead, CMS believes this item is better characterized as part of indirect costs like office rent or administrative expenses.

The one point of confusion or concern for CMS in valuing these codes concerns the total physician time to be assigned to each code. As CMS notes, the RUC separately averaged the survey results for pre-service, day of service, and post-service times, and the survey results for total time, with the result that, for some of the codes, the sum of the average times associated with the three service periods does not match the RUC-recommended total time, which was the average of the respondents’ total time. A simple example illustrates how this might occur:

  Pre-Service Time Intra-Service Time Post-Service Time Total Time
Respondent A 1 2 1 4
Respondent B 2 2 0 4
Respondent C 3 2 1 6
Median 2 2 1 4

CMS is concerned by the fact that if one adds up the medians of the individual time components (which is 5 [2+2+1] in the illustration above), the total does not equal the median of total time among all respondents (which is 4 in this illustration).

CMS proposes to adopt the RUC-recommended times, in which total time reflects the median of total time among all respondents rather than the sum of the medians for the three components of total time. However, CMS seeks comment on how it should address the discrepancies in median total times versus sum of the median component times. CMS believes this has implications both for valuation of individual codes and for MPFS rate setting in general, as the intra-service times and total times are used as references for valuing many other services under the MPFS and the programming used for MPFS rate setting requires that the component times sum to the total time. Specifically, CMS requests comment on which times it should use, and how it should resolve differences between the sum of the components and median total times when they conflict.

Georgia Academy of Family Physicians Response- Office/Outpatient E/M Visit Revaluation (CPT codes 99201 through 99215)

The Georgia Academy appreciates and strongly supports CMS’ proposal to adopt the RUC-recommended work RVUs for all the office/outpatient E/M codes and the new prolonged services add-on code, effective for dates of service on or after January 1, 2021. However, since most family medicine practices already operate on extremely thin margins and these services have been undervalued for decades, we implore CMS to implement these changes in 2020. We also appreciate and support the CMS proposal to maintain separate values and payment for levels two through four visits rather than implement its plan for a blended rate for those services.

However, we respectfully disagree with the CMS proposal to remove equipment item ED021 (computer, desktop with monitor) from the direct PE inputs for these codes. According to the Centers for Disease Control and Prevention (CDC), 85.9% of office-based physicians are using an EHR. Medication and problem lists must be accurately maintained by physicians during a visit using their EHRs. Furthermore, with the multiple medications now required by many patients, monitoring for drug-drug interactions becomes an essential component for patient safety and quality care. All of this makes a computer a typical, indispensable part of the medical equipment used during an office visit. Whether it’s a desktop computer with monitor or a laptop, some computer is typically being used during an office visit, and contrary to CMS’ belief, is allocated to the use of an individual patient for an individual service, just like the exam table in the room.

There is precedent for including a computer as a direct PE. There are 52 CPT codes that include equipment item ED021. For office visits, the work being performed using the computer is not administrative in nature. Rather, it is used to record, analyze, and communicate to the physician about every element of data that the clinical staff collects from the individual patient for the individual service.

In sum, the computer is dedicated solely to each patient throughout the visit to collect history, share and discuss lab and test results, and document the visit. It is an essential tool in conducting today’s office visits, and CMS should recognize it as a direct medical equipment cost. We encourage CMS to accept the RUC’s recommendation to include item ED021 (computer, desktop with monitor) among the direct PE inputs for these codes.

Georgia Academy of Family Physicians Response – Valuation of CPT Code 99XXX (Prolonged Office/Outpatient E/M)

The Georgia Academy appreciates and strongly supports CMS’ proposal to adopt the RUC-recommended work RVUs for the new prolonged services add-on code, effective for dates of service on or after January 1, 2021. However, since most family medicine practices already operate on extremely thin margins, we implore CMS to implement these changes in 2020.

Summary – Global Surgical Packages

Considering three RAND reports on the subject and CMS’ understanding that work RVUs for procedures with a global period are generally valued using magnitude estimation, CMS does not state its intent to accept the RUC recommendation to adjust the office/outpatient E/M visits for codes with a global period to reflect the changes made to the values for office/outpatient E/M visits. Instead, CMS states it will give the public and stakeholders time to study the RAND reports (which CMS makes available), along with this rule and consider an appropriate approach to revaluing global surgical procedures. CMS will continue to study and consider alternative ways to address the values for these services.

Georgia Academy of Family Physicians Response – Global Surgical Packages

Based upon analysis available from RAND and the Medicare Payment Advisory Commission, we believe the proposed recommendations put forth by CMS are the appropriate policy. Until such time that verifiable, third-party data provides a clearer justification for the inclusion of E/M codes in the global period we strongly support CMS’ decisions as outlined in the proposed rule. As CMS notes in the proposed rule and as the RUC and the surgical specialties have frequently maintained, work RVUs for procedures with a global period are generally valued using magnitude estimation rather than building blocks.

As noted in the proposed rule and as required by law, CMS is collecting data to validate the number and level of E/M services assumed to be included in global surgical services. The RAND study analyzing data collected through claims supports CMS’ intent not to accept the RUC recommendation to adjust the office/outpatient E/M visits for codes with a global period to reflect the changes made to the values for office/outpatient E/M visits. For instance, during the first 12 months of reporting post-operative visits via claims, RAND found most procedures with 10-day global periods did not have an associated post-operative visit. Further, among procedures with 90-day global periods, the ratio of observed-to-expected post-operative visits provided was only 0.39. Further, in its study of the levels of post-procedure visits, RAND found the reported physician time and work for the post-operative visits in the two 90-day global codes studied (i.e., cataract surgery and hip replacement) were generally similar—but slightly less—than the levels expected based on the E/M visits assumed to typically occur by CMS when valuing these procedures

The Office of Inspector General and others have questioned the accuracy of current assumptions underlying 10- and 90-day global codes. Until CMS can adequately address those questions, we believe it would be imprudent to adjust the E/M component because of any changes to the values of stand-alone office/outpatient visit codes 99201-99215 and we strongly support CMS’ decision in this regard. We continue to believe the best approach to this issue is to convert all codes with a 10- or 90-day global period to zero-day global periods and revalue the codes accordingly and thereby allow physicians to appropriately code and document necessary pre- and post-operative services using the E/M codes inclusive of their new values and payment amounts. For decades, physicians using these global codes have not been required to follow the E/M documentation guidelines for charting in the medical record for such visits which has been blatantly unfair to the rest of the physician community and especially primary care—it is time for the global service codes to be eliminated and level the playing field for all physicians and other clinicians.

Join GAFP for the 2019 Annual Fall CME Meeting, November 14-16

Earn up to *46 AAFP Prescribed credits and 21 AMA PRA Category 1 Credits TM. This year’s meeting will cover current topics and workshops that highlight conditions and diseases affecting our communities. We will have a lecture devoted to influenza, heart failure, and a workshop focused on implicit bias. Additionally, we will offer a pediatric track that focuses on a variety of clinical topics such as childhood Type II Diabetes, immunizations and gaming addiction. We will also offer four Knowledge Self-Assessment Modules (KSAs).

Special Guest Lecturer: Commissioner of the Georgia Department of Public Health, Kathleen Toomey, MD, MPH will give an update on the state of public health in Georgia. Dr. Toomey is an epidemiologist and board-certified family physician and oversees 159 county health departments in 18 health districts, and various public health programs.

View the Conference Agenda

Register for the Conference

Please note that the GAFP Fall Family Medicine Weekend room block is currently sold out.

At this time, there is no availability at the Atlanta Evergreen Marriott over the needed dates. The GAFP staff is currently working to secure alternate accommodations at nearby hotels. To join the waitlist for hotel accommodations, please click here. You will be immediately notified once lodging becomes available.

*Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.

 

 

Georgia Academy of Family Physicians Awards Alice House, MD, FAAFP its 2019 Family Physician of the Year Award

The Georgia Academy of Family Physicians (GAFP) awarded Alice House, MD, FAAFP its 2019 Family Physician of the Year Award, for her extraordinary service to the organization and the family physicians it supports.

Dr. House is the Dean at Mercer University School of Medicine in Columbus. She is also a family medicine specialist at Nephrology Associates.

Dr. House was raised in Buena Vista, Georgia, and graduated from Tri-County High School that served Marion, Webster and Schley counties. She earned degrees in biology and psychology from Macon State College (now Middle Georgia State University) and her medical degree at Mercer University School of Medicine. She completed her residency in family medicine at the Medical Center of Central Georgia (now Medical Center, Navicent Health) and went on to obtain the distinction of Fellow of the American Academy of Family Physicians.

Certified by the American Board of Family Medicine, Dr. House was in private practice in Byron for several years where she served as chief of staff at Peach Regional Hospital before joining the Mercer University School of Medicine faculty in 2002. She also served as medical director of Elberta Healthcare Center from 1998-2015.

Dr. House has demonstrated over 25 years of leadership to the Georgia Academy of Family Physicians through her work on the Board of Directors and the Executive Committee. She has also served as the GAFP President and Board Chair during that time.  Her leadership and direction have helped keep the GAFP as one of the premier American Academy of Family Physicians chapter in the country.

Dr. House will be among a group of five individuals honored by GAFP at the Annual Fall CME meeting in November.

ALL MEMBER NOTICE!!  You’re Invited! Congress of Delegates First Session Webinar/Conference Call

October 17th – 6:00pm

GAFP Members – Join the Discussion

The first meeting of the Congress of Delegates will be via conference call / webinar on Thursday, October 17, at 6 pm. All members are invited and encouraged to attend. The call-in number is 1-800-791-2345, participate code #76232. There will also be the ability to view the webinar via this link: Congress of Delegates: 1st Session.

Members are invited to speak to resolutions of interest or concern to you. Final 2019 resolutions will be available Friday, October 11 on the GAFP website.

The second session of the Congress of Delegates will be from 8 am until 12:30 pm on Saturday, November 16, at the GAFP Annual Meeting at the Evergreen Marriott Conference Resort in Stone Mountain, GA.  The second session is where final discussion and voting occurs. COD delegates can speak and vote for your district during the second session. Below is the current list of delegates.

 

2019 District Delegates as of 10/7/19

Speaker: Carl McCurdy, MD, FAAFP

Vice Speaker: Samuel “Le” Church, MD, MPH, FAAFP

 

District 1 Delegates

Loy “Chip” Cowart, MD

Mah-Fri Fomukong, MD

Angela Gerguis, MD

Peter Rives, MD

 

District 2 Delegates

Mike Busman, MD

Zita Magloire, MD

Laura Guadiana-Sanchez, MD

Michael Satchell, MD

District 3 Delegates

Donald Griffin, MD

Alice House, MD

Shika Shah, MD

Jagdish Shukla, MD

Michael Sims, MD

Daniel Singleton, MD

 

District 3 Alternates

Joy Adegbile, MD

Shawnte Hall-Kraft, MD

Beulette Hooks, MD

Beverley Ann Townsend, MD

 

District 4 Delegates

Andrea Andrews, MD

Jody Bahnmiller-Brasil, MD

Amy Bailey, MD

Emily Herndon, MD

Hira Kohli, MD

Monica Parker, MD

Vera Reaves, MD

James Short, MD

Tina Ann Thompson, MD

 

District 5 Delegates

Shameeka Hunt-McElhaney, MD

Allison Key, MD

Carolyn Smallwood, DO

Irshad Syed, MD

 

District 6 Delegates

Tameka Byrd, DO, MPH

Monique Davis-Smith, MD

Sandhya Ramayya, MD

Eddie Richardson, MD

Bert Wall, MD

Brandan Wormsbacher, MD

 

District 7 Delegates

Kelly Culbertson, MD

Christina Douglass, MD

Pamela Obi, MD

Leonard Reeves, MD

Stephanie Stutz, DO

 

District 8 Delegates

Thomas Fausett, MD

Jay Floyd, MD

Richard Wheeler, MD

 

District 8 Alternates

Jairaj Goberdhan, MD

District 9 Delegates

Philip Kimsey, MD

Monica Newton, DO, MPH

Nkiruka Udejiofor, MD

 

District 10 Delegates

Edward Agabin, MD

Julie Dahl-Smith, DO

Jacqueline DuBose, MD

Joseph Hobbs, MD

Stalina Gowdie, MD

 

District 11 Delegates

Susana Alfonso, MD

Marva Ayers, MD

Teresa Beck, MD

Michelle Cooke, MD

Kim Eubanks, MD

Wanda Gumbs, MD

Riba Kelsey-Harris, MD

Hogai Nassery, MD

Jun Ro, MD

 

Resident Delegates:

Babatunde Ajibola, MD

Oluwole Akintayo, MD

Tarah Henderson, MD

Julie Kostanjevec, MD

Philomise Moncion, MD

Jemese Richards-Boyd, MD

 

Student Delegates:

Chinomnso Ekeke – Morehouse

Caleb Swindell – Mercer University

Catherine Waldron – Memorial Health